Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives
暂无分享,去创建一个
P. Murali Doraiswamy | Christopher A. Hostage | Jeffrey R. Petrella | Kingshuk Roy Choudhury | J. Petrella | P. Doraiswamy | K. Roy Choudhury | Erika J. Lampert | E. Lampert | C. Hostage
[1] David M Holtzman,et al. Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance , 2011, Science Translational Medicine.
[2] R. Honea,et al. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease , 2010, Neurology.
[3] Mert Sabuncu,et al. Genetic variation and neuroimaging measures in Alzheimer disease. , 2010, Archives of neurology.
[4] Keith A. Johnson,et al. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease , 2013, Neurobiology of Aging.
[5] Rachel L. Mistur,et al. Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease , 2009, Neurology.
[6] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[7] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[8] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[9] Rachel L. Mistur,et al. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism , 2007, Proceedings of the National Academy of Sciences.
[10] R. Mayeux,et al. Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.
[11] Mark E. Schmidt,et al. The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans , 2010, Alzheimer's & Dementia.
[12] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[13] C. Jack,et al. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers , 2008, Brain : a journal of neurology.
[14] Andrew J. Saykin,et al. Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.
[15] D. Balota,et al. Role of family history for Alzheimer biomarker abnormalities in the adult children study. , 2011, Archives of neurology.
[16] Anders M. Dale,et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.
[17] K. Davis,et al. Patterns of risk in first-degree relatives of patients with Alzheimer's disease. , 1994, Archives of general psychiatry.
[18] R. Honea,et al. Maternal family history is associated with Alzheimer's disease biomarkers. , 2012, Journal of Alzheimer's disease : JAD.
[19] R. Green,et al. Estimating risk curves for first-degree relatives of patients with Alzheimer’s disease: The REVEAL study , 2004, Genetics in Medicine.
[20] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup , 2011 .
[21] Sterling C. Johnson,et al. Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults , 2012, Neurology.
[22] M. Weiner,et al. Alzheimer's Disease Neuroimaging Initiative. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease , 2009 .
[23] S. Vallabhajosula,et al. Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents , 2013, Neurobiology of Aging.
[24] F. Jessen,et al. Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study , 2010, Molecular Psychiatry.
[25] Amity E. Green,et al. Effects of ApoE4 and maternal history of dementia on hippocampal atrophy , 2012, Neurobiology of Aging.
[26] R. Honea,et al. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease , 2011, Neurology.
[27] Frank M LaFerla,et al. Animal models of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[28] S. Potkin,et al. Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort , 2010, Neurology.
[29] R. Tanzi. The genetics of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.